2-oxo-hept-3-ene-1,7-dioate hydratase activity
|
phenotype |
|
Molecular Function
|
14
|
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Adenocarcinoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
543
|
432
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Adenoma
|
group |
Neoplasms
|
Neoplastic Process
|
1183
|
103
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Adenoma of large intestine
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
452
|
213
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Associated Pulmonary Arterial Hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
22
|
4
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Benign Prostatic Hyperplasia
|
disease |
Male Urogenital Diseases
|
Disease or Syndrome
|
770
|
91
|
0.010 |
None |
1.000 |
1 |
|
2004 |
2004 |
Body Height
|
phenotype |
|
Organism Attribute
|
1903
|
3972
|
0.100 |
None |
1.000 |
1 |
1
|
2019 |
2019 |
Bone Density
|
phenotype |
|
Clinical Attribute
|
138
|
654
|
0.100 |
None |
1.000 |
1 |
1
|
2018 |
2018 |
Carcinogenesis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Neoplastic Process
|
6243
|
355
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 1
|
disease |
|
Finding
|
166
|
374
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 10
|
disease |
|
Finding
|
166
|
370
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 12
|
disease |
|
Finding
|
166
|
373
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
COLORECTAL CANCER, SUSCEPTIBILITY TO, 3
|
phenotype |
|
Finding
|
165
|
368
|
0.100 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Colorectal Carcinoma
|
disease |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
5473
|
1962
|
0.400 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Colorectal Neoplasms
|
group |
Digestive System Diseases; Neoplasms
|
Neoplastic Process
|
1296
|
609
|
0.400 |
None |
1.000 |
2 |
2
|
2019 |
2019 |
Cystic echinococcosis
|
phenotype |
Pathological Conditions, Signs and Symptoms; Neoplasms; Infections
|
Disease or Syndrome
|
43
|
2
|
0.010 |
None |
1.000 |
1 |
|
2014 |
2014 |
Essential Hypertension
|
disease |
Cardiovascular Diseases
|
Disease or Syndrome
|
445
|
293
|
0.010 |
None |
1.000 |
1 |
2
|
2019 |
2019 |
Familial primary pulmonary hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
30
|
2
|
0.630 |
None |
1.000 |
4 |
|
2011 |
2015 |
Familial pulmonary arterial hypertension
|
disease |
|
Disease or Syndrome
|
12
|
1
|
0.300 |
None |
1.000 |
1 |
|
2011 |
2011 |
Fibrosis, Liver
|
disease |
Pathological Conditions, Signs and Symptoms; Digestive System Diseases
|
Disease or Syndrome
|
1179
|
64
|
0.010 |
None |
1.000 |
1 |
|
2019 |
2019 |
Hamartomatous polyposis
|
disease |
Pathological Conditions, Signs and Symptoms; Neoplasms
|
Disease or Syndrome
|
23
|
3
|
0.300 |
None |
1.000 |
1 |
|
2015 |
2015 |
Hypertensive disease
|
group |
Cardiovascular Diseases
|
Disease or Syndrome
|
2322
|
1085
|
0.010 |
None |
1.000 |
1 |
|
2009 |
2009 |
Idiopathic pulmonary arterial hypertension
|
disease |
Respiratory Tract Diseases
|
Disease or Syndrome
|
776
|
24
|
0.660 |
None |
0.857 |
7 |
|
2009 |
2018 |
Idiopathic pulmonary hypertension
|
disease |
Respiratory Tract Diseases; Cardiovascular Diseases
|
Disease or Syndrome
|
161
|
5
|
0.510 |
None |
1.000 |
3 |
|
2009 |
2015 |
Increased pulmonary vascular resistance
|
phenotype |
|
Finding
|
4
|
|
0.100 |
None |
|
0 |
|
|
|